Breaking News Headlines Today | Ground News

See every side of every news story

Express Pharma image

News from Express Pharma

Ground News rates Express Pharma’s media bias as unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, AllSides, and Media Bias/Fact Check.

Express Pharma’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Express Pharma

Where is Express Pharma located?Express Pharma's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Express Pharma News

Experts Hail Budget 2026 Health Push, Flag Biopharma, District-Level Care and Affordability as Game-Changers

Nirmala Sitharaman · India

Experts Hail Budget 2026 Health Push, Flag Biopharma, District-Level Care and Affordability as Game-Changers

67% Right coverage: 6 sources

Union Budget 2026 boosts health spending above ₹1 lakh crore, launches the ₹10,000-crore Biopharma Shakti initiative, expands trauma centres and regional medical hubs and prioritises research, workforce training and medical tourism — winning praise from doctors and industry experts.See the Story

View from India Newsletter India-EU trade deal: Pragmatic move or geopolitical statement?

Opinion · India

View from India Newsletter India-EU trade deal: Pragmatic move or geopolitical statement?

Coverage: 4 sources

View from India Newsletter India-EU trade deal: Pragmatic move or geopolitical statement?See the Story

Rs 10k cr 'Biopharma Shakti' an investment in India’s health, innovation future: Industry

Health · India

Rs 10k cr 'Biopharma Shakti' an investment in India’s health, innovation future: Industry

New Delhi, Feb 1 (PTI) The government has made a decisive investment in the country’s health and innovation future by proposing an outlay of Rs 10,000 crore in the budget for the development of the biopharma sector over the next five years, according to the industry leaders. The Union Budget 2026-27 has also proposed setting up 1,000 clinical trial sites and strengthening the Central Drugs Standard Control Organisation. “By placing biopharma amo…See the Story

Breaking News Topics Related to Express Pharma